CXCL1 and peripheral arterial disease: Hence, we used the human chemokine antibody array to explore the plasma levels of chemokines (3 PAD and 3 health controls) and found that growth-related oncogene (GRO) and neutrophil activating protein2 (NAP2) chemokines had highest fold change expression between the two groups (Fig. 6A and B).